Drug intelligence / Profile preview

PRO 2000

Development stage
Phase 3
Lead developer
Endo International
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Vaginal
01

Overview

PRO 2000 is an investigational synthetic polyanionic compound developed as a topical vaginal microbicide for the prevention of sexually transmitted infections, primarily HIV. It is designed to be applied vaginally prior to sexual intercourse and acts by blocking the entry of pathogens such as HIV into human cells. Mechanistically, it binds to HIV gp120 and interferes with virus attachment and/or fusion with CD4+ T cells. Additionally, it interacts with CD4 and CXCR4 receptors on host cells and exhibits antagonistic activity at CXCR4, which may explain its greater activity against X4-tropic viruses compared to R5-tropic viruses. Laboratory studies have shown activity against other sexually transmitted pathogens including herpes simplex virus (HSV), chlamydia, and Neisseria gonorrhoeae. Despite promising preclinical results, large phase III clinical trials demonstrated that PRO 2000 was not effective in preventing HIV transmission in women[1][2][3][6].

Brand names
LomarTamolDaxadDarvanDispersant NNO
Other names
Naphthalene 2-sulfonate polymerNaphthalene2-sulfonate polymerNaphthalene-2-sulfonate polymerPolynaphthalene sulphonate2-Naphthalenesulfonic acid, sodium salt, polymer with formaldehyde
02

Targets

gp120 (HIV-1 envelope glycoprotein (gp120/gp41) epitopes)CXCR4 (C-X-C motif chemokine receptor 4)

Beyond the preview

Go deeper on PRO 2000.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRO 2000.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call